Clinical trials for Diphtheria

Information provided by WHO International Clinical Trials Registry

The clinical trials below are relevant to Diphtheria. For all clinical trials, go to clinical trials search

This list shows clinical trials for Diphtheria

Search result filters
Recruitment status
Trials for children:
Country of trial:

You have searched for the following terms

  • Diphtheria
Title Recruitment status Location
A phase II, open-label, randomised study to assess the safety and immunogenicity of a birth dose of GSK Biologicals’ reduced-antigen-content tri-component pertussis vaccine followed by routine paediatric vaccination at 2, 4, 6 and 12-18 months of age, and to explore the ability of this schedule to accelerate the acquisition of pertussis antibodies. - PA-TRICOMP-005 Not Recruiting United Kingdom
A phase II, open-label, randomized, multicentre study to evaluate the feasibility of GSK Biologicals’ DTPa-IPV/Hib-MenC-TT vaccine co-administered with Prevenar compared with Pediacel co-administered with Menjugate and Prevenar, when given in healthy infants as a three-dose primary vaccination course at 2, 3 and 4 months of age and to evaluate Menitorix given to these children as a booster dose at 12 months of age - DTPA-IPV=HIB-MENC-TT-001 PRI Not Recruiting United Kingdom
Safety, Tolerability and Immunogenicity of Meningococcal B Recombinant Vaccine Administered With or Without Routine Infant Vaccinations to Healthy Infants According to Different Immunization Schedules Not recruiting United Kingdom
Immunogenicity and Safety of GSK Biologicals' Boostrix Polio Vaccine in 3 and 4-year-old Children Not recruiting United Kingdom
A Phase IV, randomised study to evaluate the immune response of UK infants receiving DTaP/Hib/IPV, meningococcal C conjugate and pneumococcal conjugate vaccines, antibody persistence and responses to booster doses in the second year of life. (code: Sched2) - Sched2 Not Recruiting United Kingdom
Study of Antibody Responses After a Dose of Tetravalent Meningococcal Diphtheria Conjugate Vaccine in Children Not recruiting United Kingdom
Antibody Responses Following Meningococcal Tetravalent (A, C, Y, and W-135) Conjugate Vaccination in Healthy Adults Not recruiting United Kingdom
Hepatitis B Vaccination in Infants Not recruiting United Kingdom
Phase III (main) study of medicinal product, code ICT-107, along with standard anti-tumour therapy, temozolomide (TMZ), in patients who have newly diagnosed glioblastoma (brain tumour), after surgery along with TMZ and radiation therapy Not Recruiting United Kingdom
Study of the Safety and Immune Response of a Meningococcal Vaccine Administered to Healthy Infants Not recruiting United Kingdom

Page last reviewed: 16/02/2015

Next review due: 30/06/2017